Free Trial

Novozymes A/S to Issue Dividend of $0.19 (OTCMKTS:NVZMY)

Novozymes A/S logo with Basic Materials background

Key Points

  • Novozymes A/S has declared a dividend of $0.1856 per share, with a dividend yield of 88.0%, payable to stockholders on September 11th.
  • The stock opened at $64.20, with a 52-week price range between $53.95 and $75.99, and a market cap of $30.06 billion.
  • Novozymes A/S specializes in producing industrial enzymes, microorganisms, and probiotics for various industries globally, including food and beverage.
  • MarketBeat previews the top five stocks to own by October 1st.

Novozymes A/S (OTCMKTS:NVZMY - Get Free Report) announced a dividend on Saturday, August 30th, investing.com reports. Shareholders of record on Wednesday, September 3rd will be paid a dividend of 0.1856 per share by the biotechnology company on Thursday, September 11th. This represents a yield of 88.0%. The ex-dividend date of this dividend is Tuesday, September 2nd.

Novozymes A/S Stock Performance

Shares of NVZMY stock remained flat at $62.75 during mid-day trading on Wednesday. 104,909 shares of the company's stock were exchanged, compared to its average volume of 40,789. The company has a 50-day moving average price of $67.68 and a 200-day moving average price of $65.30. Novozymes A/S has a 12-month low of $53.95 and a 12-month high of $75.99. The company has a market capitalization of $29.39 billion, a price-to-earnings ratio of 39.72, a PEG ratio of 1.26 and a beta of 0.93. The company has a quick ratio of 1.04, a current ratio of 1.66 and a debt-to-equity ratio of 0.11.

Analyst Ratings Changes

Separately, Zacks Research cut shares of Novozymes A/S from a "strong-buy" rating to a "hold" rating in a research report on Monday, August 25th. Two equities research analysts have rated the stock with a Strong Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Novozymes A/S presently has an average rating of "Moderate Buy".

View Our Latest Analysis on NVZMY

Novozymes A/S Company Profile

(Get Free Report)

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.

Read More

Dividend History for Novozymes A/S (OTCMKTS:NVZMY)

Should You Invest $1,000 in Novozymes A/S Right Now?

Before you consider Novozymes A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novozymes A/S wasn't on the list.

While Novozymes A/S currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets Are Sliding: Where to Find Opportunity
5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum
$15 Billion for Cybersecurity: The Government’s Next Big Push

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines